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The recent demonstrations that migration inhibitory factor (MIF) (1-4), chem-
otactic factor (5), mitogenic factor (6, 7), and lymphotoxin (8) can be produced by
B as well as T lymphocytes have raised serious doubts about the validity of in
vitro assays for cell-mediated immunity as indices of T-cell function . Yet there
are a number ofhuman disease states in which the biological significance of the
in vitro production of mediators by B cells may be called into question . For
example, lepromatous leprosy and chronic mucocutaneous candidiasis are char-
acterized by specific functional T-cell deficiency and failure of macrophage
killing of ingested organisms despite high levels of circulating antibodies to the
offending parasite . If B cells are capable of producing the mediators of delayed-
type hypersensitivity, why are they ineffective at initiating macrophage activa-
tion in these diseases?
We have pursued the question whether B cells can be activated by antigen to
produce MIF in a model that excludes participation of T cells by virtue of an
immune response (Ir) gene restriction . Strain 2 guinea pigs respond to immuniza-
tion with the 2,4-dinitrophenyl (DNP) derivative ofpoly-L-lysine (PLL) with the
production of antibody and delayed-type hypersensitivity ; strain 13 animals are
nonresponders (9) . However, strain 13 animals can respond to DNP-PLL when
the molecule is complexed to an immunogenic carrier, such as ovalbumin (10) .
In this situation, anti-DNP antibodies are produced, but delayed-type cutaneous
reactivity and blastogenesis to DNP-PLL are absent (11), indicating an absence
of T cells capable of responding to DNP-PLL . This system allows us to test
directly the question whether MIF can be produced by interaction of antigen
with primed B cells in the absence of competent T cells.
Materials and Methods
PLL hydrobromide (mol wt 90,000) was obtained from New England Nuclear, Boston, Mass .
Guinea pig albumin (GPA) was prepared from strain 13 guinea pig serum by the method of
Schwert (12) . DNP32-PLL and DNP2u-GPA were prepared as previously described (13) . The sub-
scripts refer to the average number of DNP groups per molecule . Twice recrystallized hen
ovalbumin (Ova) was obtained from Miles Laboratories Inc ., Elkhart, Ind .
Preparation ofDNP-PLL-Ova Complexes .
￿
Equimolaramounts ofOvawere added to DNP-PLL
in 0.075M NaCI dropwise with the formation of a precipitate .
* Supported by U. S . Public Health Service grants AI 07118, AI 09807, and AI 10702 .
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Anti-DNP antibodies were measured by thehapten-binding assay of Stupp et al . (14) .
Strain 2 and 13 guinea pigs, 500-600 g, from the National Institutes of Health breeding colony
were sensitized with a complex of DNP-PLL-Ova (100 lAg each) in Freund's complete adjuvant
(H 3711a) administered in a total of 0.4 ml distributed over four foot pads . The animals were skin
tested with 10 pg/0 .1 ml between day 14 and day 21 to confirm their responder/nonresponder
status, and animals were used within 14 days of skin testing .
To maximize the number ofBcells available, spleens were used in all experiments . The spleen
cellswere isolated by gentle homogenization in aglasshomogenizerandwashed threetimes . They
were cultured in the presence or absence of antigenat a cell density of 15 x 106 cells/ml in 1.5 ml
per Leighton tube for 24 h in an atmosphere of 7% CO, in air at 37°C . The medium was Eagle's
minimal essential medium (MEM) containing 5% guinea pig serum. The supernates were har-
vested andeither used directly or quick frozen . Before testingthey were adjusted to 15% in guinea
pig serum and tested neat and following 1:3 dilution . Migrating cells were 48-h oil-induced
peritoneal cells of Hartley strain guinea pigs . In five of six experiments controls consisted of
supernates from spleen cells cultured in medium alonewhichwere reconstituted with theappropri-
ate dose of stimulating antigen . Percent inhibition was given by the formula :
MI = I - migration area ofsupernates ofantigen-stimulated cultures
￿
x 100.
area of control supernates reconstituted with antigen
Because there was some indication that supernates containing reconstituted antigen were
somewhat more toxic than those containing antigen cultured with cells in one experiment com-
parisons were made between spleen cells of sensitized and normal guinea pigs cultured with the
antigen. In this experiment, migration inhibition was calculated by the following formula :
% MI = 1 -
￿
migration in supernates of sensitized cells plus antigen
￿
x 100
migration in supernates of nonsensitized cells plus antigen
The virus plaque assay was carried out on lymph node cells from the same donors using
vesicular stomatitis virus as the probe described previously (15) .
Results and Discussion
Strain 2 and strain 13 guinea pigs immunized with DNP-PLL complexed to
ovalbumin produced essentially equal amounts of anti-DNP antibodies (Table
I) . Spleen cells from donors of both strains produced MIF in vitro upon culture
with the immunizing complex, DNP-PLL-Ova (Table II) . In contrast, however,
only strain 2 guinea pig spleen cells were capable of being activated by DNP-
PLL to produce significant amounts ofMIF (Table II) .
When the virus plaque assay which enumerates activated T cells (21) was
applied to the lymph node cellsfrom the same donors, virus-plaque-forming cells
(V-PFC) were stimulated by DNP-PLL-Ova in both responder and nonresponder
strains (Table III) . However, strain 13 lymphocytes could not be stimulated by
DNP-PLL, while strain 2 cells produced 2.4 V-PFC/103 above background, thus
confirming the validity of the virus plaque assay as a useful index of T-cell
reactivity .
The simplest interpretation to be drawnfrom these data would be that B cells
interacting with antigen in the absence of functional T cells are incapable of
producing MIF, and that antigen-induced MIF production is a T-cell dependent
response . Because it is clear that both B cells and T cells are capable of MIF
production, the MIF assay may be useful qualitatively to indicate T-cell activa-
tion, but the degree of migration inhibition cannot be regarded asa quantitative
reflection of the number of sensitized T cells. Our results are not inconsistent
with those demonstrating products of activated lymphocytes in supernates of T-
cell-depleted lymphoid populations, but rather would argue that it may be1308 BLOOM AND SHEVACH
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TABLE I
Anti-DNP Antibody Response by Strain2 and Strain 13 Guinea
Pigs Immunized with DNP-PLL-Ova in CFA
Strain
￿
No . of animals
Binding of [ 3H]DNP-Lysine by
antiserum dilution*
2
￿
5
￿
55-5 15-2
13
￿
5
￿
56-4
￿
9-2
* Serum anti-DNP antibody is expressed as percent binding of 0 .1 ml 10 - " M
[ 3H]DNP-lysine by 0 .1 ml of the diluted serum . The arithmetic mean and
standard error are shown .
TABLE II
MIFProduction by Strain2 and Strain 13 Guinea Pig Spleen Cells Stimulated with
DNP-PLL and DNP-PLL-Ova
* Calculation in five of six experiments was made by comparing migration of supernates of sensitized cells
cultured with antigen with reconstituted supernates cells being cultured without antigen, antigen being
reconstituted after removal of cells . In one experiment the controls consisted ofnonsensitized spleens cultured
with antigen. Since there was no significant difference in the two methods, the data were pooled .
$ - paired Student's t test .
TABLE III
T-Cell Responses ofLymph Node Cells ofStrain2 and Strain 13
Guinea Pigs Immunized with DNP-PLL-Ova Measured by
the Virus Plaque Assay*
t AV-PFC represents the increase in V-PFC above the medium controls .
" A single representative experiment is presented; four experiments using this
assay yielded similar results.
Antigen No . of
experiments
Percent migration
Strain 2
inhibition* (-SE)
Strain 13
i°#
Supernates 1 :1
DNP-PLL, 10 Ag/ml 6 46 .3 - " 9 .5 18 .8 - 6 .9 <0.05
DNP-PLL, 3 jig/ml 6 33 .5 - 7 .1 12 .3 - 7 .1 <0.10
DNP-PLL-Ova, 10 Fig/ml 6 50 .2 - 9 .0 43 .5 - 9 .8 >0.60
DNP-PLL-Ova, 3 Ag/ml 6 50.4 - 4 .8 40 .7 - 9 .2 >0.40
DNP-GPA, 100 fag/ml 3 6.0 - 11 .4 4 .7 - 17 .6 >0.50
Supernates 1 :3
DNP-PLL, 10 pg/ml 5 39.8 = 9 .9 5 .2 - 3 .3 <0.02
DNP-PLL, 3 tag/ml 5 43 .8 '- 1 .7 1 .8 - 1 .8 <0.001
DNP-PLL-Ova, 10 fig/ml 5 29.0 - 8 .1 24 .6 :t 10 .9 >0.70
DNP-PLL-Ova, 3 Ng/ml 5 29.3 - 5 .4 31 .0 - 14 .6 >0.90
DNP-GPA, 100 jAg/ml 3 -10 .0 = 15.7 -0 .3 - 0 .6 >0.70
Stimulating antigen Strain V-PFC/103
cells
AV-PFC/103
cells#
DNP-PLL, 10 t g/ml 2 4 .7 2 .4
13 1 .7 -0 .3
DNP-PLL-Ova, 10 Wg/ml 2 5 .1 2 .8
13 3 .8 1 .8
None 2 2 .3
13 2 .0BLOOM AND SHEVACH
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difficult, if not impossible, to remove all competent T cells by physical separa-
tion methods. It may be recalled that as few as 0.6% immune lymphocytes
produced migration inhibition of normal peritoneal cells (22) ; similarly, small
numbers of contaminating T cells may be sufficient to activate B cells to produce
MIF. The data would suggest that B cells may require two signals for activation
to produce MIF, binding of antigen to their receptor and a second signal
produced by T cells in this case.
The most difficult data to reconcile with these conclusions are those of Rocklin
et al. (3) who reported that human MIF was produced by purified B as well as T
cells. There are several possible explanations for the discrepancies : (a) their
method for purifying B lymphocytes, i.e. adherence to anti-Ig columns, may
retain some T cells, possibly activated T-cells containing Fe-receptors which
could have been scored as B cells after elution with Ig; or (b) binding of B cells to
the anti-Ig columns may lower the threshold for activation of B cells by antigen
to produce MIF, analogously to the demonstration by Wahl et al. (5) that
immune complexes can activate nonimmune B lymphocytes to produce macro-
phage chemotactic factor.
In the present experiments, MIF production by immune spleen cells was
carrier specific in that DNP-GPA failed to elicit MIF in either strain 2 or 13
animals. Although the carrier specificity of the direct migration inhibition test
was demonstrated in 1964 by David et al. (16), those experiments were carried
out on immune peritoneal exudate cells, a population deficient in B cells which
might have been capable of responding to hapten on heterologous carriers. A
similar concern applies to the interpretation of direct migration inhibition
studies using DNP-PLL (17).
There are a number of reservations about extrapolating from our results to
those in other systems. First, it is not inconceivable that differences in patterns
of response may exist between guinea pig and human lymphocyte populations.
Secondly, the existence of a specific T-cell defect in strain 13 guinea pigs, with
respect to DNP-PLL, does not exclude the possibility of additional Ir gene-
controlled defects at the B-cell level as well. Although it has been demonstrated
that the number of specific antigen-binding B lymphocytes does not differ
between responder and nonresponder guinea pigs (18) and that the anti-DNP
antibody clones appear to be identical (19), recent studies of Ir-gene controlled
responses in certain mouse strains have raised the possibility that some nonre-
sponder strains may have defects in both B- and T-cell populations (20) . An Ir-
gene controlled restriction on the ability of strain 13 B cells to respond to DNP-
PLL cannot be ruled out at this time.
Summary
The question whether B lymphocytes are capable of being activated by anti-
gen in the absence of functional T cells was investigated in a model that
excludes participation of T cells by virtue of an immune response gene restric-
tion. Strain 2 guinea pigs are capable of responding to immunization with DNP-
PLL, whereas strain 13 animals are not. In the present experiments, animals of
both strains were immunized with DNP-PLL complexed to ovalbumin (DNP-
PLL-Ova) under conditions in which equal titers of antibodies to DNP were131 0
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produced by both strains. The failure of T cells of strain 13 animals to respond to
DNP-PLL was confirmed by the virus plaque assay. While spleen cells from both
strains produced MIF after stimulation with DNP-PLL-Ova, in response to
DNP-PLL only strain 2 spleens were able to produce MIF. Cells from neither
strain could be activated by DNP-guinea pig albumin to produce MIF.
We conclude that B lymphocytes are incapable of being stimulated by antigen
in the absence of T cells, and that MIF production is a thymus-dependent
response. While the results indicate that MIF production is a valid qualitative
assay for T-cell competence, since MIF can be produced by B and T cells, the
degree of migration inhibition cannot be regarded as a quantitative measure of
T-cell function.
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